Droits & Societe
New EU Guidance for Clinical Trials During Emergencies
The Accelerating Clinical Trials in the EU (ACT EU) initiative has issued draft guidance on how to conduct clinical trials during public health emergencies. The guidance aims to ensure that clinical trials can continue safely and effectively during crises, facilitating the development of new treatments and vaccines. It covers aspects such as trial design, data collection, and ethical considerations specific to emergency situations. Stakeholders are invited to provide feedback on the draft guidance.
New EU rules to ensure quicker, safer clinical trials during health crises.